ロード中...
Rivastigmine for Alzheimer's disease
BACKGROUND: Alzheimer's disease is the commonest cause of dementia affecting older people. One of the therapeutic strategies aimed at ameliorating the clinical manifestations of Alzheimer's disease is to enhance cholinergic neurotransmission in the brain by the use of cholinesterase inhibi...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2015
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7050299/ https://ncbi.nlm.nih.gov/pubmed/26393402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001191.pub4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|